Characterization of complete responders to combination nivolumab (nivo) and ipilimumab (ipi) in patients (pts) with advanced, unresectable melanoma Meeting Abstract


Authors: Warner, A. B.; Shoushtari, A. N.; Houghton, S.; Panageas, K.; Chapman, P. B.; Wolchok, J. D.; Postow, M. A.
Abstract Title: Characterization of complete responders to combination nivolumab (nivo) and ipilimumab (ipi) in patients (pts) with advanced, unresectable melanoma
Meeting Title: 54th Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title: Journal of Clinical Oncology
Volume: 36
Issue: 15 Suppl.
Meeting Dates: 2018 Jun 1-5
Meeting Location: Chicago, IL
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2018-05-20
Start Page: 502s
Language: English
ACCESSION: WOS:000442916003326
PROVIDER: wos
DOI: 10.1200/JCO.2018.36.15_suppl.9552
Notes: Meeting Abstract: 9552 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Jedd D Wolchok
    905 Wolchok
  2. Michael Andrew Postow
    361 Postow
  3. Paul Chapman
    326 Chapman
  4. Katherine S Panageas
    512 Panageas